Member Info for kand72

Fantastic news

I bet there are still placing shares at 9p out there

Linkedin

https://www.linkedin.com/posts/christopher-mcconville-53b834a9_clinicaltrialsgov-activity-7421927769019785216-GMeA?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAlnBd0BpB6PHzg0dVDHb53BAvB9SOxW2wo

CTG page

https://clinicaltrials.gov/study/NCT07356973

I am delighted to share that CRISM Therapeutics Phase II clinical trial for ChemoSeed, the locally implantable irinotecan drug delivery platform is now officially published on ClinicalTrials.gov (Identifier: NCT07356973).

This study represents a key step in translating my work on ChemoSeed, designed to deliver high local doses of chemotherapy directly to the resection margins of glioblastoma tumours, into clinical evaluation. Preclinical research showed promising control of residual tumour cells and a pathway to more effective, less toxic treatment strategies.

I want to thank the entire multidisciplinary team, our clinical partners, collaborators, CDMOs, CROs and especially the patients and families who make clinical research possible. Our progress reflects years of collaborative effort in drug delivery, oncology, and translational medicine.

Onward as we continue advancing this innovation toward meaningful impact for patients facing glioblastoma.

1st patient was supposed to be Feb.... Now March. Last I read was that patient recruitment was in effect Yes it's still q1

I think they said to expect the phase 2 trial to start March slightly delayed, they are currently manufacturing the production run of chemoseed for the trial. I like many am watching this probably as an obsession! if the ODD arrives then I suspect we will see positive movement upwards with the price. Its been very stagnant for a long time now considering the potential here for a £5m cap.